Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

Abstract

The current immunosuppressive regimens allow to achieve the excellent one year organ survival, exceeding in renal transplantation 90%, with acute rejection rate below 15%. However, this medal has the reverse side, and it is price to pay. 54% of the kidney allograft is lost due to the recipient death with the functioning graft, mainly due to cardiovascular diseases, infection and malignancy. 40% of the graft failure is caused by chronic allograft injury (CAI) which encompasses calcineurin inhibitor nephrotoxicity, chronic rejection, and toxicity occurring simultaneously with inadequate, not controlling alloresponse immunosuppression. The present strategies of initial post transplantation immunosuppressive treatment are diversified based on the evaluation of the recipient immunologic risk and of the delayed graft function occurrence threat. For low immunologic risk recipients, calcineurin inhibitor containing regimen; with or without anti CD25 antibody are recommended. High immunologic risk recipients are treated by polyclonal anti T-cell antibodies, with subsequent calcineurin inhibitor introduction. The polyclonal anti T-cell antibodies are also administrated in the delayed graft function appearance or when expectation for it's appearance is high. The main long-term goal in the post transplantation immunosuppressive treatment is to achieve the balance between efficacy and toxicity of the immunosuppressive regimen, with the reduction of the overall side effect "load" on patients. For that purpose two general approach are applied: corticosteroid withdrawal and avoidance protocols, and calcineurin inhibitor withdrawal/minimization protocols.

Keywords: Transplantation, Cardiovascular Diseases, nephrotoxicity

Add Comment 0 Comments

In Press

07 Mar 2024 : Original article  

Outcomes of Renal Transplantation in ANCA-Associated Vasculitis

Ann Transplant In Press; DOI: 10.12659/AOT.943433  

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358